All Stories

  1. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions
  2. AhR Deletion Promotes Aberrant Morphogenesis and Synaptic Activity of Adult-Generated Granule Neurons and Impairs Hippocampus-Dependent Memory
  3. Specific Features of SVZ Neurogenesis After Cortical Ischemia: a Longitudinal Study
  4. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke
  5. Test repositioning for functional assessment of neurological outcome after experimental stroke in mice
  6. Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia
  7. Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke
  8. Cytokines and Chemokines in Stroke
  9. Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomography
  10. Seladin-1/DHCR24 Is Neuroprotective by Associating EAAT2 Glutamate Transporter to Lipid Rafts in Experimental Stroke
  11. Complexity of the cell–cell interactions in the innate immune response after cerebral ischemia
  12. Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
  13. Aging increases microglial proliferation, delays cell migration, and decreases cortical neurogenesis after focal cerebral ischemia
  14. Rational modulation of the innate immune system for neuroprotection in ischemic stroke
  15. The Complexity of the Innate Immune System Activation in Stroke Pathogenesis
  16. Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia
  17. Neutrophils scan for activated platelets to initiate inflammation
  18. L-Kynurenine/Aryl Hydrocarbon Receptor Pathway Mediates Brain Damage After Experimental Stroke
  19. Intravenous Immunoglobulin Promotes Antitumor Responses by Modulating Macrophage Polarization
  20. Toll-like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia
  21. The high-mobility group I-Y transcription factor is involved in cerebral ischemia and modulates the expression of angiogenic proteins
  22. Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways
  23. Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPAR  and 5-LO-dependent pathways
  24. N2 Neutrophils, Novel Players in Brain Inflammation After Stroke
  25. Oct-2 Transcription Factor Binding Activity and Expression Up-Regulation in Rat Cerebral Ischaemia is Associated with a Diminution of Neuronal Damage In Vitro
  26. miRNA expression is modulated over time after focal ischaemia: up-regulation of miR-347 promotes neuronal apoptosis
  27. Amelioration of ischemic brain damage by peritoneal dialysis
  28. Neuronal Excitotoxicity after Carotid Angioplasty and Stent Placement Procedures
  29. Silent Information Regulator 1 Protects the Brain Against Cerebral Ischemic Damage
  30. Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke
  31. Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion
  32. Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation
  33. Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke
  34. Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury
  35. Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
  36. Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model
  37. Implication of the toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis
  38. Longitudinal studies of ischemic penumbra by using 18 F-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats
  39. A Mouse Model of Hemorrhagic Transformation by Delayed Tissue Plasminogen Activator Administration After In Situ Thromboembolic Stroke
  40. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome
  41. Neuroprotection and Recovery: Recent Data at the Bench on Citicoline
  42. Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model
  43. The Cannabinoid WIN55212-2 Promotes Neural Repair After Neonatal Hypoxia–Ischemia
  44. Role of NO-synthases and cyclooxygenases in the hyperreactivity of male rabbit carotid artery to testosterone under experimental diabetes
  45. Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications☆
  46. Plasma levels of 15d-PGJ2are not altered in multiple sclerosis
  47. mTOR/S6 Kinase Pathway Contributes to Astrocyte Survival during Ischemia
  48. Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome
  49. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning
  50. Synthesis of Lipoxin A4 by 5-Lipoxygenase Mediates PPAR -Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke
  51. Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia
  52. Activation of Liver X Receptors Promotes Neuroprotection and Reduces Brain Inflammation in Experimental Stroke
  53. Implication of Glutamate in the Expression of Inducible Nitric Oxide Synthase After Oxygen and Glucose Deprivation in Rat Forebrain Slices
  54. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats
  55. Toll-Like Receptor 4 Is Involved in Subacute Stress–Induced Neuroinflammation and in the Worsening of Experimental Stroke
  56. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke
  57. The Increase of Circulating Endothelial Progenitor Cells After Acute Ischemic Stroke Is Associated With Good Outcome
  58. Involvement of IL-1β in acute stress-induced worsening of cerebral ischaemia in rats
  59. The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn Rats
  60. Statin treatment withdrawal in ischemic stroke: A controlled randomized study
  61. TNF-α downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation
  62. The Metabolic Syndrome and Stroke
  63. The Role of PPARγ on Restoration of Colonic Homeostasis After Experimental Stress-Induced Inflammation and Dysfunction
  64. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke
  65. Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke
  66. Ischemic Preconditioning Reveals that GLT1/EAAT2 Glutamate Transporter is a Novel PPARγ Target Gene Involved in Neuroprotection
  67. Increased Body Iron Stores Are Associated With Poor Outcome After Thrombolytic Treatment in Acute Stroke
  68. The role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats
  69. Characterization of the Neuroprotective Effect of the Cannabinoid Agonist WIN-55212 in an In Vitro Model of Hypoxic-Ischemic Brain Damage in Newborn Rats
  70. A polymorphism in theEAAT2promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke
  71. TNF–α converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis
  72. TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning
  73. Targets of Cytoprotection in Acute Ischemic Stroke: Present and Future
  74. Dual role of nitric oxide in adult neurogenesis
  75. Mitochondrial respiratory chain and free radical generation in stroke
  76. The Prediction of Malignant Cerebral Infarction by Molecular Brain Barrier Disruption Markers
  77. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms
  78. Immature rat brain slices exposed to oxygen–glucose deprivation as an in vitro model of neonatal hypoxic–ischemic encephalopathy
  79. Increased Plasma Levels of 15-Deoxy Δ Prostaglandin J 2 Are Associated With Good Outcome in Acute Atherothrombotic Ischemic Stroke
  80. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats
  81. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia
  82. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport
  83. The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats
  84. TNFR1 Upregulation Mediates Tolerance after Brain Ischemic Preconditioning
  85. Stress Increases Susceptibility to Oxidative/Nitrosative Mucosal Damage in an Experimental Model of Colitis in Rats
  86. Activity of Inducible and Neuronal Nitric Oxide Synthases in Colonic Mucosa Predicts Progression of Ulcerative Colitis
  87. Role of nitric oxide after brain ischaemia
  88. TNF-alpha accounts for short-term persistence of oxidative status in rat brain after two weeks of repeated stress
  89. Ozone exposure induces iNOS expression and tyrosine nitration in rat aorta
  90. 3,4-Methylenedioxymethamphetamine increases interleukin-1β levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion
  91. In Vitro Ischemic Tolerance Involves Upregulation of Glutamate Transport Partly Mediated by the TACE/ADAM17-Tumor Necrosis Factor-  Pathway
  92. The release of tumor necrosis factor-α is associated with ischemic tolerance in human stroke
  93. Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke
  94. Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress
  95. L-Arginine Levels in Blood as a Marker of Nitric Oxide–Mediated Brain Damage in Acute Stroke: A Clinical and Experimental Study
  96. Effect of subacute and chronic immobilisation stress on the outcome of permanent focal cerebral ischaemia in rats
  97. Induction of Cyclooxygenase-2 Accounts for Restraint Stress-Induced Oxidative Status in Rat Brain
  98. Neuroprotective effects of aspirin in patients with acute cerebral infarction
  99. Expression and Function of Tumour Necrosis Factor-α-Converting Enzyme in the Central Nervous System
  100. Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies
  101. Upregulation of TACE/ADAM17 after Ischemic Preconditioning is Involved in Brain Tolerance
  102. Stress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide
  103. Aspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in rats
  104. The Increase in TNF-α Levels Is Implicated in NF-κB Activation and Inducible Nitric Oxide Synthase Expression in Brain Cortex after Immobilization Stress
  105. Inhibition of Glutamate Release via Recovery of ATP Levels Accounts for a Neuroprotective Effect of Aspirin in Rat Cortical Neurons Exposed to Oxygen-Glucose Deprivation
  106. Chronic Stress Induces the Expression of Inducible Nitric Oxide Synthase in Rat Brain Cortex
  107. IMPLICATION OF TNF-α CONVERTASE (TACE/ADAM17) IN INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION AND INFLAMMATION IN AN EXPERIMENTAL MODEL OF COLITIS
  108. N-(3-(Aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats
  109. Up-regulation of TNF-α convertase (TACE/ADAM17) after oxygen–glucose deprivation in rat forebrain slices
  110. Two different NO-dependent mechanisms account for the low virulence of a non-mycelial morphological mutant of Candida albicans
  111. Glutathione Depletion, Lipid Peroxidation and Mitochondrial Dysfunction Are Induced by Chronic Stress in Rat Brain
  112. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor κB-mediated mechanisms
  113. Fructose-1,6-bisphosphate inhibits the expression of inducible nitric oxide synthase caused by oxygen-glucose deprivation through the inhibition of glutamate release in rat forebrain slices
  114. Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices
  115. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal
  116. Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones
  117. Use of brain slices in the study of pathogenic role of inducible nitric oxide synthase in cerebral ischemia-reperfusion
  118. Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck
  119. Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite
  120. Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat
  121. Neuronal death induced by SIN-1 in the presence of superoxide dismutase: protection by cyclic GMP
  122. Protective effect of N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen–glucose deprivation
  123. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices
  124. Peroxvnitrite Causes Aspartate Release from Dissociated Rat Cerebeliar Granule Neurones
  125. Inhibition of morphine withdrawal by lamotrigine: involvement of nitric oxide
  126. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
  127. Correlation between brain nitric oxide synthase activity and opiate withdrawal
  128. Nitric oxide donors inhibit platelet spreading on surfaces coated with fibrinogen but not with fibronectin
  129. Paradoxical fate and biological action of peroxynitrite on human platelets.
  130. Activation of adrenal medullary L-arginine: nitric oxide pathway by stimuli which induce the release of catecholamines
  131. Diadenosine Tetraphosphate Is Co-Released with ATP and Catecholamines from Bovine Adrenal Medulla
  132. Characterization of Two Chromaffin Cell Populations Isolated from Bovine Adrenal Medulla
  133. Muscarinic receptors in separate populations of noradrenaline- and adrenaline-containing chromaffin cells
  134. Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae
  135. Voltage-dependence of nitrendipine provides direct evidence for dihydropyridine receptor coupling to calcium channels in intact cat adrenals